The aim of this study was to investigate the efficacy and safety of high-dose chemotherapy (HDCT) for the treatment of patients with advanced testicular cancer.
Department of Urology, Division of Transfusion Medicine, School of Medicine, Kanazawa University, 13-12 Takaramachi, Kanazawa 920-8640, Japan. tak1019@kenroku.kanazawa-u.ac.jp